Daniel Shoemaker

Daniel Shoemaker

56 year
Health Technology
Consumer Services
Commercial Services

Profile

Daniel D. Shoemaker holds the position of Chief Scientific Officer for Fate Therapeutics, Inc. He previously was Chief Scientific Officer at ICX Biosystem, Chief Scientific Officer at GHC Technologies, Inc. and Director-Target Discovery at Merck Research Laboratories Massachusetts LLC. Dr. Shoemaker received a doctorate from Stanford University and an undergraduate degree from the University of California, Santa Barbara.

Former positions of Daniel Shoemaker

CompaniesPositionEnd
FATE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2021-06-29
ICX Biosystem Chief Tech/Sci/R&D Officer 2008-12-31
Chief Tech/Sci/R&D Officer 2002-12-31
Corporate Officer/Principal 2002-12-31
Director/Board Member -
See the detail of Daniel Shoemaker's experience

Training of Daniel Shoemaker

Stanford University Doctorate Degree
University of California, Santa Barbara Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Shoemaker's experience

Connections

51

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
FATE THERAPEUTICS, INC.

Health Technology

Private companies4

Health Technology

Commercial Services

Health Technology

ICX Biosystem

See company connections
  1. Stock
  2. Insiders
  3. Daniel Shoemaker